Skip to main content
LISATA THERAPEUTICS, INC. logo

LISATA THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · LSTA ISIN · US1280583022 LEI · 5493002287F62M3EGQ04 US Manufacturing
Open in API
Filings indexed 1,093 across all filing types
Latest filing 2012-01-12 Regulatory Filings
Country US United States of America
Listing US LSTA

About LISATA THERAPEUTICS, INC.

https://www.lisata.com/

Lisata Therapeutics is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for advanced solid tumors and other major diseases. The company's core technology is the proprietary CendR Platform®, designed to enhance the targeted, tissue-penetrating delivery of anti-cancer drugs to solid tumors. The platform also aims to target non-cancerous, immunosuppressive cells within the tumor microenvironment, seeking to improve the efficacy of a patient's immune system and immunotherapies in fighting cancer.

Recent filings

Filing Released Lang Actions
CURRENT REPORT
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated January 12, 2012. It announces an event regarding a subsidiary issuing a press release about an agreement to provide manufacturing and regulatory services. The document includes a press release as an exhibit but does not contain financial statements or detailed financial data. The length is 3719 characters, which is relatively short and consistent with a current report announcing an event rather than a full financial report. There is no indication of quarterly or annual financial results, audit information, or management discussion. The document is primarily an announcement of a corporate event and a press release, fitting the definition of a Regulatory Filing (RNS) as a general regulatory announcement that does not fit other specific categories.
2012-01-12 English
CURRENT REPORT
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated January 10, 2012. It reports an event related to the expansion of intellectual property protection for a product candidate, including a press release as an exhibit. The document is relatively short (3607 characters) and primarily serves as an announcement of an event and includes a press release. It does not contain financial statements, detailed financial data, or comprehensive management discussion. It is not an earnings release, annual report, or interim report. The nature of the filing is to inform the market of a material event, which fits the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2012-01-11 English
OWNERSHIP DOCUMENT
Director's Dealing
2012-01-06 English
OWNERSHIP DOCUMENT
Director's Dealing
2012-01-06 English
OWNERSHIP DOCUMENT
Director's Dealing
2012-01-06 English
OWNERSHIP DOCUMENT
Director's Dealing
2012-01-06 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.